Recursion CFO Ben Taylor gets $5M equity grant, enhanced vesting on Exscientia awards

RECURSION PHARMACEUTICALS, INC.

Ben Taylor (CFO) enters employment letter with Exscientia AI Ltd, base salary £400K/year.
Annual cash bonus target 25% of base salary; equity bonus target also 25%.
New equity grant of $5M (50% RSUs, 50% options) vesting over 4 years, subject to board approval.
Pre-existing Exscientia awards (Exchanged Awards) fully vest if terminated w/o cause or resign for good reason within 12 months of Nov 20, 2024 closing.
Employment requires 3 months' notice/pay in lieu; garden leave may offset severance plan benefits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.